Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Whole Body Vibration on Postmenopausal Risk-Factors in Elderly Women
This study is ongoing, but not recruiting participants.
First Received: April 24, 2008   Last Updated: August 11, 2008   History of Changes
Sponsors and Collaborators: University of Erlangen-Nürnberg
Elsbeth-Bonhoff-Stiftung, Berlin
Information provided by: University of Erlangen-Nürnberg
ClinicalTrials.gov Identifier: NCT00667667
  Purpose

There is general agreement that physical exercise can positively influence osteoporotic fracture risk along two pathways: first by reducing the risk of falls via an improvement of fall related neuromuscular abilities; second by increasing bone strength. Whole body vibration (WBV) training has recently been proposed as a new approach for prevention and treatment of osteoporosis. Animal studies have shown evidence that WBV may be an effective method to improve bone mass, architecture and strength. However, the results of human WBV training studies are rather heterogeneous.

In the Erlangen Longitudinal Vibration Study II (ELVIS II), a randomized, controlled 12 month lasting study we determine the effect of a thrice weekly WBV training on two different devices on the osteoporotic risk factors: bone mineral density, falls and neuromuscular performance. Particular we compare a bipedal vertical oscillating Plate with a plate which rotates around a central axis leading to a side-alternating loaning.


Condition Intervention Phase
Postmenopausal
Device: vertical vibration device (Vibrafit whole body vibration platform)
Device: side alternating vibration device (Board 3000 whole body vibration platform)
Behavioral: stretching and wellness (control group)
Phase III

Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Effect of Whole Body Vibration Training on Two Different Devices on Osteoporotic Risk Factors in Postmenopausal Women. A Randomized Controlled Trial.

Resource links provided by NLM:


Further study details as provided by University of Erlangen-Nürnberg:

Primary Outcome Measures:
  • Bone Mineral Density [ Time Frame: Baseline, 12 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • muscle strength [ Time Frame: baseline, 12 months ] [ Designated as safety issue: No ]
  • Quality of life [ Time Frame: baseline, 12 month ] [ Designated as safety issue: No ]
  • falls [ Time Frame: daily over 12 month ] [ Designated as safety issue: No ]

Estimated Enrollment: 108
Study Start Date: April 2008
Estimated Study Completion Date: August 2009
Estimated Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Active Comparator
vertical vibration device (using Vibrafit whole body vibration platforms)
Device: vertical vibration device (Vibrafit whole body vibration platform)
3 sessions/week 15 min each, leg exercises performed on whole body vibration platforms with vertical device
2: Active Comparator
side-alternating vibration device (using Board 3000 whole body vibration platforms)
Device: side alternating vibration device (Board 3000 whole body vibration platform)
3 sessions/week 15 min each, leg exercises performed on whole body vibration platforms with side alternating device
3: Sham Comparator
wellness-control group
Behavioral: stretching and wellness (control group)
2x10 weeks with 1 session/week of low volume, low intensity wellness training over 12 months

  Eligibility

Ages Eligible for Study:   60 Years to 75 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • females 60 - 75 years old
  • caucasian race

Exclusion Criteria:

  • CHD-diseases
  • thrombosis, embolism
  • fractures at lumbar spine or hip
  • secondary osteoporosis
  • hyperparathyroidism
  • medication, diseases with impact on muscle or bone
  • hip or knee implant
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00667667

Locations
Germany
Institute of Medical Physics, University of Erlangen-Nurnberg
Erlangen, Germany, 91052
Sponsors and Collaborators
University of Erlangen-Nürnberg
Elsbeth-Bonhoff-Stiftung, Berlin
Investigators
Principal Investigator: Simon O von Stengel, PhD University of Erlangen-Nürnberg
Study Chair: Wolfgang K Kemmler, PhD Instiute of Medical Physics
Study Director: Willi A Kalender, Prof., PhD University of Erlangen-Nürnberg
  More Information

Additional Information:
Publications:
Responsible Party: Institute of Medical Physics ( Simon von Stengel )
Study ID Numbers: OFZ-Elvis-II
Study First Received: April 24, 2008
Last Updated: August 11, 2008
ClinicalTrials.gov Identifier: NCT00667667     History of Changes
Health Authority: Germany: Federal Institute for Drugs and Medical Devices;   Germany: Federal Ministry of Education and Research

Keywords provided by University of Erlangen-Nürnberg:
whole body vibration
exercise
postmenopausal
BMD
bone
elderly females
Caucasian race

ClinicalTrials.gov processed this record on September 02, 2009